A Spanish study slows lung cancer relapses

A Spanish study slows lung cancer relapses


A team of researchers from Spanish lung cancer group (GECP) has achieved stop relapses after surgery in lung tumors In initial stadiums. To do this, they have evaluated the Immunotherapy combined with chemotherapy as adjuvant treatment in 206 patients from 30 hospitals from all over the country.

The study data, presented during the World lung cancer congress (WCLC25) In Barcelona, ​​they have shown that Only 20.4 % of patients treated with combination fell after a three -year follow -upcompared to 38.8 % of those who received only chemotherapy.

“He Non -microcytic lung cancer (CPNM) in early stages presents a high relapse rateeven when the tumor has completely removed by surgery. In recent years there have been several essays with immunotherapy after surgery, but with disparate results and without exploring the combination with chemotherapy in this context, “said the president of the GECP and principal investigator of the work, Dr. Mariano Provencio.

He Sensitivity analysis has also shown that treatment has achieved reduce the risk that the disease reappears to 46 %which affects an increase in survival without relapse.

Bigstock Doctor Shows Results To Old Pa 162997394
Doctor showing the results of an x ​​-ray of the lungs. Source: Bigstock

Although the incorporation of immunotherapy has made around 25 % of patients suffered adverse effectscompared to 14 % of the only chemotherapy group, scientists have stressed that these effects have been manageable and that the balance between risk and benefit is “clearly positive” For patients.

“We needed strategies that were beyond operation and chemotherapy standard. With NADIM ATJUVANT We take an important step in that path. If the improvements in disease -free survival and global survival are confirmed, the study could redefine the standard of adjuvant treatment in lung cancer“Dr. Provencio said.

Finally, researchers have pointed out the need to carry out a Greater follow -up of the study to confirm the long -term benefits, and have insisted on the “very promising” results.



Source link

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *